Europe’s Unified Patent Court Postpones Opening & Sunshine Period
EPO’s Transitional Measures Remain Unchanged
Executive Summary
Patent applicants are being given an extra two months to equip themselves with the tools they will need to use the UPC’s electronic case management system.
You may also be interested in...
EPO Supports Early Unitary Patent Uptake From 1 January
The European Patent Office has adjusted the starting date of its transitional measures for applicants that want their patent to have unitary effect under the coming Unified Patent Court system.
EMA Probe Finds No Link Between GLP-1s And Suicidal Thoughts & Actions
After reviewing the evidence from non-clinical studies, clinical trials, post-marketing surveillance data and other studies, the European Medicines Agency said there was no need to update the product information for 11 diabetes and weight management drugs.
English Funding For Aquipta Targets AbbVie’s Migraine Drug To 170,000 People
Aquipta is the first oral treatment that NICE has recommended for preventing chronic migraines in the fourth-line setting, and the second oral treatment for episodic migraines in the same setting. The drug has already secured reimbursement in Scotland, Sweden and Israel.